Literature DB >> 29687700

Impella: pumps overview and access site management.

Francesco Burzotta1, Giulio Russo2, Leonardo Previ2, Piergiorgio Bruno2, Cristina Aurigemma2, Carlo Trani2.   

Abstract

The Impella left ventricular support system consists of two main components: a family of different ventricular support catheters with a microaxial pump to be placed across the aortic valve and a single external controller which is connected to activate and control the pump function. Four Impella left ventricular support catheters are available: Impella 2.5, Impella CP, Impella 5.0 and Impella LD. Impella 2.5 and Impella CP are designed for percutaneous peripheral insertion, have respectively a 12F and 14F maximal diameter at the pump level and are capable of providing up to 2.5 and 4.1 liters per minute, respectively. Impella 5.0 and Impella LD have 21F maximal diameter at the pump level and are designed for surgical insertion through, respectively, a peripheral artery (femoral or axillary) or the aorta. The Impella CP or 5.0 are commonly selected for cardiogenic shock patients. The femoral approach represents the most adopted access site for percutaneous Impella insertion. Yet, it requires the presence of suitable aorto-iliac-femoral arterial axis for retrograde advancement of the Impella pump. The axillary artery is usually the main alternative approach for surgical insertion in the patients with unfavorable peripheral anatomy or for patients requiring prolonged assistance. When adopting Impella pumps, maximal attention should be paid to the access site management before, during and after cardiac assistance in order to minimize the risk of vascular complications.

Entities:  

Mesh:

Year:  2018        PMID: 29687700     DOI: 10.23736/S0026-4725.18.04703-5

Source DB:  PubMed          Journal:  Minerva Cardioangiol        ISSN: 0026-4725            Impact factor:   1.347


  9 in total

1.  A simple technique to obtain postprocedural antegrade angiographic control in single-access Impella-protected PCI.

Authors:  Francesco Burzotta; Enrico Romagnoli; Cristina Aurigemma; Piergiorgio Bruno; Stefano Cangemi; Francesco Bianchini; Carlo Trani
Journal:  Health Sci Rep       Date:  2022-07-04

Review 2.  ECMO and Impella Support Strategies as a Bridge to Surgical Repair of Post-Infarction Ventricular Septal Rupture.

Authors:  Garrett Coyan; Neesha Anand; Mahnoor Imran; Hernando Gomez; Raj Ramanan; Holt Murray; Saurabh Sanon; Pyongsoo Yoon; David Kaczorowski; Johannes Bonatti
Journal:  Medicina (Kaunas)       Date:  2022-04-28       Impact factor: 2.948

3.  Long-Term Outcomes of Extent of Revascularization in Complex High Risk and Indicated Patients Undergoing Impella-Protected Percutaneous Coronary Intervention: Report from the Roma-Verona Registry.

Authors:  Francesco Burzotta; Giulio Russo; Flavio Ribichini; Anna Piccoli; Domenico D'Amario; Lazzaro Paraggio; Leonardo Previ; Gabriele Pesarini; Italo Porto; Antonio Maria Leone; Giampaolo Niccoli; Cristina Aurigemma; Diana Verdirosi; Filippo Crea; Carlo Trani
Journal:  J Interv Cardiol       Date:  2019-04-09       Impact factor: 2.279

4.  Post-Myocardial Infarction Ventricular Septal Defect: No Reprieve From Doom?

Authors:  Giulio Russo; Maurice Enriquez-Sarano; Maurizio Taramasso
Journal:  JACC Case Rep       Date:  2022-03-02

Review 5.  A Review of the Impella Devices.

Authors:  Rami Zein; Chirdeep Patel; Adrian Mercado-Alamo; Theodore Schreiber; Amir Kaki
Journal:  Interv Cardiol       Date:  2022-04-08

6.  PRospective REgistry of PAtients in REfractory cardiogenic shock-The PREPARE CardShock registry.

Authors:  Dirk von Lewinski; Lukas Herold; Christian Stoffel; Sascha Pätzold; Friedrich Fruhwald; Siegfried Altmanninger-Sock; Ewald Kolesnik; Markus Wallner; Peter Rainer; Heiko Bugger; Nicolas Verheyen; Ursula Rohrer; Martin Manninger-Wünscher; Daniel Scherr; Dietmar Renz; Ameli Yates; Andreas Zirlik; Gabor G Toth
Journal:  Catheter Cardiovasc Interv       Date:  2022-07-13       Impact factor: 2.585

Review 7.  Effect of Atrioventricular Dyssynchrony on Impella Hemodynamics: Mechanism and Its Clinical Implications.

Authors:  Raj Baljepally; Hassan Tahir
Journal:  Cardiol Res       Date:  2021-07-09

8.  Of Size and Men: A Call for Larger Trials and Meta-Analyses on Vasopressors During General Anesthesia.

Authors:  Giuseppe Biondi-Zoccai; Elena Cavarretta; Giacomo Frati; Francesco Versaci
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-09-15       Impact factor: 2.628

9.  Can we have a rationalized selection of intra-aortic balloon pump, Impella, and extracorporeal membrane oxygenation in the catheterization laboratory?

Authors:  Giulio Russo; Francesco Burzotta; Cristina Aurigemma; Daniela Pedicino; Enrico Romagnoli; Carlo Trani
Journal:  Cardiol J       Date:  2020-12-21       Impact factor: 2.737

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.